Aeromonas hydrophila: A Comprehensive Guide

Aeromonas hydrophila is a Gram-negative bacterium of the family Aeromonadaceae, commonly found in freshwater, brackish water, and soil. It is recognized as a colonizer and pathogen of cold-blooded animals, including fish, reptiles, and amphibians.

The bacterium’s genome is approximately 4.5 to 5 Mbp with a GC content of around 61 to 62%, and many strains carry plasmids encoding virulence and antibiotic resistance genes. It produces virulence factors like hemolysin and aerolysin and exhibits notable resistance to antibiotics like ampicillin, with some strains showing multidrug resistance. Due to its widespread distribution and significance in human health and aquaculture, it is considered an important microorganism in medical and microbiological research.

Taxonomy and Classification of Aeromonas hydrophila

Domain: Bacteria

Kingdom: Pseudomonadota

Phylum: Pseudomonadota

Class: Gammaproteobacteria

Order: Aeromonadales

Family: Aeromonadaceae

Genus: Aeromonas
Species: A. hydrophila

Morphology and Microscopy of Aeromonas hydrophila

• It is a gram-negative, rod-shaped bacterium with rounded ends.
• It may be straight, slightly curved, coccobacillary, or filamentous.
• Approximately 0.3 to 1µm wide by 1.0 to 3.5 µm long.
• Motile by polar flagella
• Non-spore-former
• Capsulated

They appear as short pink-colored rods after Gram staining under the microscope.

Cultural and Growth Characteristics of Aeromonas hydrophila

• Facultative anaerobes
• Optimum temperature: 25°C to 35°C
• Optimum pH: 5.5 to 9
• It can grow well on ordinary media like nutrient agar, blood agar, and MacConkey agar.
• On Nutrient Agar: Colonies are smooth, circular, convex, colorless to pale yellow with a characteristic odor.
• On Blood Agar: 1-3mm in diameter, large, round, circular, convex, translucent, and β-hemolytic colonies are formed.
• On MacConkey Agar: Pale, colorless to slightly pink colonies are formed.
• On Aeromonas Medium Base: Small, circular, green colonies with darker cores are formed.
• On Tryptone Soya Agar: Round, smooth, yellowish or creamy colonies are formed.
• On Rimler Shotts Agar: Colonies are smooth, spherical, small, convex, and yellowish in color.

Biochemical and Identification Tests of Aeromonas hydrophila

Pathogenesis of Aeromonas hydrophila

• Infections begin when the bacterium enters the host through contaminated food or water, damaged skin, gills, or the gastrointestinal tract.
• Using its polar flagellum, fimbriae, and outer membrane proteins, it attaches to epithelial surfaces, establishes colonization, and causes invasion of the host’s mucosa.
• After reaching the mucosa, the flagellum is essential for motility, adhesion, and invasion.
• This motility, along with chemotaxis, allows the bacteria to reach the target tissue of the mucosa.
• The bacteria then form biofilms, which stimulate their persistence and protect them from host immune defenses.
• Once established, the bacterium produces a variety of toxins and extracellular enzymes such as aerolysin, hemolysin, enterotoxins, proteases, and other enzymes.
• Aerolysin and hemolysin cause pore formation and lysis of host cells, leading to tissue necrosis and hemorrhage, while enterotoxins obstruct intestinal epithelial function, resulting in fluid secretion, inflammation, and diarrhea.
• Proteases and other enzymes degrade connective tissue and cellular components, facilitating bacterial invasion and dissemination.
• The bacterium also possesses iron-acquisition systems and surface structures like lipopolysaccharide and capsule that help it evade phagocytosis and complement-mediated killing.
• In severe cases, it may penetrate the bloodstream, causing septicemia and systemic organ damage.
• Similarly, in fish, these organisms may lead to motile Aeromonas septicemia characterized by hemorrhagic lesions, ulceration, ascites, and high mortality. In contrast, in humans, they generally cause gastroenteritis, wound infections, and sometimes life-threatening systemic disease.

Virulence Factors of Aeromonas hydrophila

Secretion Systems

-Type II Secretion System

–It is essential for the transport of toxins and enzymes outside the cell.

–It secretes a variety of virulence factors such as aerolysin, amylases, DNases, and proteases.

-Type III Secretion System

–It acts as a molecular needle, introducing effector toxins into the host cells.

–It is co-regulated by contact with host cells, cytotoxic enterotoxin Act, DNA adenine methyltransferase, flagella, lipopolysaccharides, DNA methylation, temperature, calcium/magnesium levels, and quorum sensing, while requiring effectors to have the appropriate secretion signal.

-Type IV Secretion System

–It acts similarly to a phage tail, permitting the administration of virulence factors into host cells through valine glycine repeat G proteins and hemolysin-coregulated protein, which acts as an antimicrobial pore-forming protein when secreted or as a structural protein.

Biofilm Formation

–It is a structured bacterial community enclosed in an extracellular matrix that protects it from antibiotics and immune clearance and promotes persistence in the environment and host.

Flagella 

–It helps in initial attachment to epithelial cells and promotes colonization of mucosal surfaces.

–It enables the movement of bacteria towards host tissues.

–It is essential for biofilm formation.

Pili

–It is a hair-like surface appendage that helps in attachment to host epithelial cells.

–It assists in binding to specific receptors on gut and skin tissues.

–It helps in the stabilization of colonization and the formation of biofilm.

Outer Membrane Proteins

–It is the structural protein found in the bacterial outer membrane.

–It helps in adhesion to host cells.

–It assists in nutrient transport and supports the formation of biofilm.

Aerolysin

–It is a key pore-forming toxin that is secreted as an inactive protoxin, which binds to the host cell membrane and forms pores in the membrane.

– It helps in cell lysis, hemolysis, tissue necrosis, and damage.

–It assists in vascular leakage.

Hemolysin

–It is a diverse group of multifunctional enzymes that play a crucial role in the pathogenesis of A. hydrophila.

–It is a cytolytic toxin that targets RBCs and other cells.

–It assists in the lysis of RBCs and releases iron for bacterial growth.

–It causes hemorrhage and tissue injury and results in inflammation.

Cytotonic Enterotoxin

–It increases intracellular cAMP and cGMP and causes fluid and electrolyte secretion.

–It contributes to watery or secretory diarrhea.

Extracellular Enzymes

-Proteases

–It breaks down host proteins such as collagen and antibodies.

–It helps in tissue destruction and immune evasion.

-Elastase

–It degrades elastin present in connective tissue.

–It helps in tissue breakdown, vascular damage, and the spread of infection.

-Lipases

–It hydrolyzes lipids in the cell membrane.

–It helps in cell membrane disruption and tissue necrosis.

-Phospholipases

–It breaks phospholipids present in the membrane.

–It helps in cell lysis and enhances inflammation.

-DNases

–It degrades extracellular DNA.

–It escapes from neutrophil extracellular traps (NETs) and facilitates bacterial spread.

-Gelatinases

–It degrades gelatin and connective tissue proteins.

–It enhances tissue invasion and lesion expansion.

Capsule

–It prevents phagocytosis and reduces complement activation.

–It enhances survival in the blood.

Lipopolysaccharide (LPS)

–It is an endotoxin component that triggers inflammation.

–It can lead to septic shock in severe infections and protect bacteria from immune attack.

Iron Acquisition Systems

-Siderophores

–It is an iron-chelating molecule that extracts iron from host transferrin and lactoferrin.

–It is essential for bacterial growth and increases virulence in iron-limited environments. 

Epidemiology of Aeromonas hydrophila

• A. hydrophila is worldwide in distribution and generally infects humans and is isolated from various sources such as fresh water, sewage, soil, fruits, and vegetables.
• Epidemiological studies have reported varying prevalence rates of A. hydrophila among diarrheal patients across different regions.
• In India, A. hydrophila was detected in 9% of 1,595 diarrheal stool samples. In Kenya, 5 out of 188 stool samples tested positive for A. hydrophila.
• Similarly, studies in China reported prevalence rates of 5.7% among 4,529 diarrheal samples collected in Shanghai and 5.2% among 1,286 samples from patients with acute diarrhea in Beijing.
• Studies from different countries have also reported the occurrence of A. hydrophila among clinical samples.
• In Spain, between January 2015 and December 2017, A. hydrophila was identified in 1 out of 98 patient samples.
• In Australia, A. hydrophila was detected in 20% of 100 analyzed samples.
• Similarly, a study conducted in Mexico and Spain analyzed 109 samples and identified A. hydrophila as the predominant species.
• Furthermore, a study carried out in Barcelona, Spain, from January 2006 to December 2012 reported 221 positive cases of Aeromonas spp., among which A. hydrophila accounted for 204 isolates.

Transmission of Aeromonas hydrophila

A. hydrophila is a waterborne and environment-associated bacterium, and its transmission occurs mainly through the following routes:

Waterborne Transmission

• It can be transmitted by drinking contaminated water from sewage, animal waste, or untreated water.
• Transmission occurs through exposure to freshwater sources such as rivers, lakes, ponds, and wells.

Foodborne Transmission

• Bacteria can be transmitted through the consumption of contaminated food, particularly undercooked fish and seafood, raw aquatic products, and improperly stored food contaminated with water.
• Through cross-contamination during food handling.

Wound and Skin Transmission

• The bacteria enter through cuts, abrasions, or traumatic injuries.
• Bacteria spread through exposure to contaminated freshwater or soil.
• Bacteria can spread via swimming in rivers or ponds with open wounds.

Direct Contact with Aquatic Animals

• Bacteria can spread through the handling of carrier or infected fish.
• Transmission occurs through exposure during fish farming or slaughtering.

Hospital-Acquired (Nosocomial) Transmission

• It can be transmitted through contaminated medical equipment or water sources in hospitals.
• It spreads through wound infections in hospitalized or immunocompromised patients.
• Transmission occurs through the use of contaminated solutions or devices.

Environmental Transmission

• Natural reservoirs are freshwater and aquatic environments where transmission occurs through contact with contaminated sediment or water and biofilms in water systems.

Animal-to-Animal Transmission

• It spreads in aquaculture systems via contaminated water and direct contact between infected fish.

Indirect Transmission

• Transmission occurs through the contaminated hands of handlers, equipment such as nets, tanks, and surfaces in aquaculture or food preparation areas.

Clinical Manifestations of Aeromonas hydrophila

Clinical Manifestations in Man

-Gastrointestinal Manifestations

–Acute Gastroenteritis

• Abdominal Cramps and Pain
• Watery Diarrhea or sometimes dysentery-like diarrhea
• Nausea
• Vomiting
• Low-grade Fever
• Self-limiting in some healthy individuals

–In severe cases

• Mucoid or Bloody Diarrhea
• Dehydration, particularly in children and the elderly

–Traveler’s Diarrhea-like Illness

• Sudden onset of watery diarrhea
• Mild Fever
• Malaise

-Skin and Soft Tissue Infections

–Wound Infections

• Cellulitis (redness, swelling, and pain)
• Purulent discharge from the wound
• Local tenderness and warmth

–Traumatic Wound Infections

• It occurs after an injury is exposed to freshwater.
• Rapid progression of infection.

–Necrotizing Fasciitis

• Severe pain disproportionate to the visible lesion
• Rapid tissue destruction
• Skin discoloration (blackening)
• Blister Formation (Bullae)
• Foul-smelling Discharge
• Systemic Toxicity

–Myonecrosis

• Muscle tissue destruction
• Severe pain and swelling
• Systemic sepsis

-Systemic Infections

–Bacteremia

• Fever
• Chills
• Malaise

–Sepsis/Septicemia

• High fever or hypothermia
• Tachycardia 
• Hypotension
• Multi-organ dysfunction

–Endocarditis

• Fever
• Heart Murmurs
• Embolic Complications

–Meningitis

• Headache
• Neck Stiffness
• Fever
• Altered Consciousness

–Hepatobiliary and Other Infections

• Cholecystitis
• Liver Abscess
• Peritonitis

–Ocular Infections

• Conjunctivitis
• Keratitis
• Eye pain, redness, and visual disturbance

Clinical Manifestations in Fish (Motile Aeromonas Septicemia)

External Signs

• Hemorrhagic lesions on the skin
• Ulcers and Erosion
• Fin rot and Tail rot
• Exophthalmia (Bulging Eyes)

Internal Signs

• Ascites (fluid in the abdomen)
• Enlarged liver, spleen, and kidney
• Hemorrhages in internal organs

Laboratory Diagnosis of Aeromonas hydrophila

Sample Collection

Microscopy

• They appear as short, straight, pink-colored rods with rounded ends after Gram staining under the microscope.
• It provides the preliminary evidence of infection but cannot definitively identify A. hydrophila.

Culture

• It can grow well on ordinary media like nutrient agar, blood agar, and MacConkey agar, and growth usually occurs within 18 – 24 hours at a temperature 25-35°C.
• On Nutrient Agar: Colonies are smooth, circular, convex, colorless to pale yellow with a characteristic odor.
• On Blood Agar: 1-3mm in diameter, large, round, circular, convex, translucent, and β-hemolytic colonies are formed.
• On MacConkey Agar: Pale, colorless to slightly pink colonies are formed.
• On Aeromonas Medium Base: Small, circular, green colonies with darker cores are formed.
• On Tryptone Soya Agar: Round, smooth, yellowish or creamy colonies are formed.
• On Rimler Shotts Agar: Colonies are smooth, spherical, small, convex, and yellowish in color.

Biochemical Tests

After culture, colonies from the incubated plates are tested for biochemical tests and

identified as A. hydrophila.

Commercial Identification Systems 

• Automated systems such as API 20E, VITEK2, and BD Phoenix are used.
• It helps in rapid identification and has high accuracy.

Molecular Methods

-Polymerase Chain Reaction (PCR)

• It targets genes including aerA, hlyA, act, alt, and ast.
• It is highly sensitive and specific.
• It helps in the rapid detection of virulence genes.

-Real-Time PCR (qPCR)

• It helps in the rapid diagnosis and quantification of bacterial load.

-DNA Sequencing

• It targets the 16S rRNA sequence and is used in the confirmation of species.

-MALDI-TOF Mass Spectrometry

• It identifies bacteria based on protein spectral patterns.
• This method is rapid, highly accurate, and used widely in modern clinical microbiology laboratories.

Treatment of Aeromonas hydrophila

Treatment of Gastroenteritis

-Mild Cases

• It is usually self-limiting.
• Oral rehydration therapy
• Adequate fluid and electrolyte replacement
• Nutritional support

-Severe Cases

• Use of intravenous fluid if dehydration is severe.
• Antibiotics may be considered for severe or prolonged diarrhea, immunocompromised patients, and systemic symptoms.

-Commonly Used Antibiotics 

• Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days or Fluoroquinolones, e.g., Ciprofloxacin 500mg twice daily for 3 days.
• Levofloxacin 
• Third-generation Cephalosporins (e.g., ceftriaxone)

Treatment of Skin and Soft Tissue Infections

-Local Wound Care

• Cleaning and irrigation of wounds
• Removal of necrotic tissue
• Regular dressing changes

-Severe Cases

• Surgical drainage of abscesses
• Debridement of necrotic tissue

-Antibiotic Therapy

• Doxycycline 100mg every 12 hours IV plus either Ciprofloxacin 500mg every 12 hours IV or Ceftriaxone 1-2 g every 24 hours IV.
• For uncomplicated cases, treatment duration should be at least 7 days, while it should be 10-14 days for severe infections.
• Combination therapy should be used rather than monotherapy to prevent the development of resistance in severe infections.

Treatment of Bloodstream Infections

• Combination therapy with doxycycline plus ciprofloxacin or ceftriaxone is used for 10-14 days.
• In immunocompromised individuals, the treatment duration should be prolonged.

Immunocompromised Patients 

• The same antibiotics used for immunocompetent patients are used, but for a prolonged duration.
• Closely monitor for treatment failure and use broad-spectrum antibiotics if conditions do not improve.
• In HIV-positive individuals, ciprofloxacin has demonstrated good clinical efficacy.

Pediatric Patients

• Trimethoprim-sulfamethoxazole or third-generation cephalosporins are used.
• Doxycycline is normally not recommended for children.

Prevention and Control of Aeromonas hydrophila

• Always consume properly treated and chlorinated water.
• Always boil water when the safety of the source of water is uncertain.
• Protect wells and water sources from sewage contamination.
• Regularly monitor water quality for microbial contamination.
• Always avoid swimming in contaminated ponds or rivers.
• Thoroughly cook fish, seafood, and other aquatic products before consumption.
• Do not consume raw or undercooked seafood.
• Avoid cross-contamination between raw and cooked foods.
• Always maintain proper refrigeration and food storage.
• Regularly wash hands with soap and clean water before eating, after handling fish or seafood, and after contact with contaminated water.
• Always cover cuts, abrasions, and burns to avoid infection.
• Always avoid contact of open wounds with potentially contaminated water.
• Clean and disinfect wounds immediately after exposure.
• Proper sterilization and disinfection of medical instruments and solutions.

Conclusion

A. hydrophila is a ubiquitous Gram-negative bacterium commonly found in freshwater environments and is recognized as an important opportunistic human and animal pathogen. Transmission occurs primarily through ingestion of contaminated food or water, exposure of wounds to contaminated aquatic environments, and contact with infected animals.

Its pathogenicity is mediated by multiple virulence factors such as aerolysin, hemolysin, enterotoxins, flagella, pili, biofilm formation, lipopolysaccharide, and extracellular enzymes that facilitate colonization, tissue damage, and immune evasion.

Clinical manifestations range from gastroenteritis with diarrhea, abdominal pain, nausea, and vomiting to wound infections, cellulitis, septicemia, and severe necrotizing infections. Laboratory diagnosis relies on culture, biochemical tests, and molecular tests. Treatment involves appropriate antimicrobial therapy.

Prevention and control depend on safe drinking water, proper food hygiene, adequate cooking of seafood, environmental sanitation, and protection of wounds from contaminated water.

Overall, A. hydrophila remains a significant waterborne and foodborne pathogen whose effective management requires timely diagnosis, appropriate treatment, and comprehensive preventive measures. 

References

1. Elsevier. (n.d.). Aeromonas hydrophila. ScienceDirect Topics. https://www.sciencedirect.com/topics/medicine-and-dentistry/aeromonas-hydrophila
2. Public Health Agency of Canada. (2011, January 4). Pathogen safety data sheet: Infectious substances – Aeromonas hydrophila. Government of Canada. https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment/aeromonas-hydrophila.html
3. Biofargo. (2026, April 9). Aeromonas hydrophila: Pathogenic mechanisms and PCR detection. Biofargo. https://biofargo.com/blogs/news/aeromonas-hydrophila-detection-pathogenesis-guide
4. Microbe Canvas. (n.d.). Aeromonas hydrophila. https://www.microbe-canvas.com/Bacteria/gram-negative-rods/facultative-anaerobic-3/catalase-positive-3/oxidase-positive/indole-positive-3/aeromonas-hydrophila.html
5. Abo-Shama, U. H., Abd El Raheem, A. A., Alsaadawy, R. M., & Sayed, H. H. (2025). Phenotypic and genotypic characterization of Aeromonas hydrophila isolated from freshwater fishes at Middle Upper Egypt. Scientific Reports, 15, 5920. https://doi.org/10.1038/s41598-025-89465-4
6. Medical Lab Notes. (2022, November 22). Aeromonas hydrophila: Introduction, identification features, keynotes, and Aeromonas footages. https://medicallabnotes.com/aeromonas-hydrophila/ 
7. Aryal, S. (2022, March 21). Biochemical test of Aeromonas hydrophila. Microbe Notes. https://microbenotes.com/biochemical-test-of-aeromonas-hydrophila/
8. Semwal, A., Kumar, A., & Kumar, N. (2023). A review on the pathogenicity of Aeromonas hydrophila and their mitigation through medicinal herbs in aquaculture. Heliyon, 9(3), e14088. https://doi.org/10.1016/j.heliyon.2023.e14088
9. Tomás, J. M. (2012). The main Aeromonas pathogenic factors. ISRN Microbiology, 2012, Article 256261. https://doi.org/10.5402/2012/256261
10. Rasmussen-Ivey, C. R., Figueras, M. J., McGarey, D., & Liles, M. R. (2016). Virulence factors of Aeromonas hydrophila: In the wake of reclassification. Frontiers in Microbiology, 7, 1337. https://doi.org/10.3389/fmicb.2016.01337
11. Pessoa, R. B. G., de Oliveira, W. F., Correia, M. T. D. S., Fontes, A., & Coelho, L. C. B. B. (2022). Aeromonas and human health disorders: Clinical approaches. Frontiers in Microbiology, 13, 868890. https://doi.org/10.3389/fmicb.2022.868890
12. Artati, D., Oman, M., Supriyanto, S., Sukarta, D., & Robisalmi, A. (2024). Validation of analytical method for Aeromonas hydrophila identification using the Analytical Profile Index (API) 20E KIT method. Jurnal Medik Veteriner, 7(1), 88–104. https://doi.org/10.20473/jmv.vol7.iss1.2024.88-104
13. Calvo Sánchez, N., Sancha Domínguez, L., Cotos Suárez, A., & Muñoz Bellido, J. L. (2025). Aeromonas Infections in Humans—Antibiotic Resistance and Treatment Options. Pathogens, 14(11), 1161. https://doi.org/10.3390/pathogens14111161
14. Dr.Oracle Medical Advisory Board. (2025, October 5). What is the recommended treatment for Aeromonas infections? Dr.Oracle. https://www.droracle.ai/articles/387660/what-is-the-recommended-treatment-for-aeromonas-infections